BSXBoston Scientific
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. 10-K, Item 1
- Employees
- 59,000
- Headquarters
- Marlborough, MA
- CEO
- Michael F. Mahoney
- Next results
- around Feb 3, 2027
What the debt is made of, and when it is due
balance sheet of Sep 30, 2026 · schedule of Dec 31, 2025The debt note's own lines, 2025-12-31
| Line, as the company names it | Kind | Rate | Fixed or floating | Amount |
|---|---|---|---|---|
| Senior Notes | Total of the lines | – | not stated | $11.3B |
| March 2032 Euro Senior Notes | Notes and bonds | 3.50% | not stated | $1.5B |
| June 2030 Notes | Notes and bonds | 2.65% | not stated | $1.2B |
| December 2027 Notes | Notes and bonds | 0.62% | not stated | $1.1B |
| March 2031 Notes 2 | Notes and bonds | 3.00% | not stated | $999.0M |
| November 2019 Aggregate Offering | – | – | not stated | $900.0M |
| March 2028 Senior Notes | Notes and bonds | 1.38% | not stated | $881.0M |
| March 2029 Euro Senior Notes | Notes and bonds | 3.38% | not stated | $881.0M |
| March 2031 Notes | Notes and bonds | 1.62% | not stated | $881.0M |
| March 2034 Notes 2 | Notes and bonds | 3.25% | not stated | $764.0M |
| March 2049 Notes | Notes and bonds | 4.70% | not stated | $650.0M |
| March 2034 Notes | Notes and bonds | 1.88% | not stated | $588.0M |
| March 2039 Notes | Notes and bonds | 4.55% | not stated | $450.0M |
| November 2035 Notes | Notes and bonds | 6.25% | not stated | $350.0M |
| March 2028 Notes | Notes and bonds | 4.00% | not stated | $344.0M |
| January 2040 Notes | Notes and bonds | 7.38% | not stated | $300.0M |
| March 2029 Notes | Notes and bonds | 4.00% | not stated | $272.0M |
| Finance Lease Obligation | – | – | not stated | $125.0M |
All 18 lines
From the debt note in the 10-K's XBRL (0000885725-26-000010), as the company tags it: by issue, by year, by currency or by kind. Lines from two ways of cutting the same debt can overlap, so they are not added up. Fixed or floating is read from the line's own name only; "not stated" when it says neither.
Left: the debt lines on the balance sheet (XBRL). Right: the principal due each year, from the debt note's maturity schedule; it can differ a little from the balance sheet, which shows the debt net of discounts and fees. Leases are not counted.
When BSX has to repay the principal of its long-term debt, from the debt note of the 10-K filed Feb 17, 2026 (balance sheet of Dec 31, 2025). Fiscal years are counted from that date.
| When | Principal due | Share | |
|---|---|---|---|
| Year 2 FY2027 | $1.1B | 10% | |
| Year 3 FY2028 | $1.2B | 11% | |
| Year 4 FY2029 | $1.2B | 10% | |
| Year 5 FY2030 | $1.2B | 11% | |
| After year 5 | $6.5B | 58% |
Principal only: interest, leases and commercial paper are not in this schedule. Hover a row for its XBRL line. Open the filing ↗
Work on BSX in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/BSX/export.csv") into a cell.